![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Lack of PK Interaction Between the Hepatitis C Virus Non-Structural Protein 5A Inhibitor MK-8742 and Methadone in Subjects on Stable Opiate Maintenance Therapy
|
|
|
Reported by Jules Levin
HEP DART 2013 December 8-12
Biennial Frontiers in Drug Development for Viral Hepatitis, The Big Island, Hawaii
AASLD: Merck at AASLD - (11/18/13)
William Marshall1, Patricia Jumes1, Wendy Yeh1, Rachel Liu1, Joanne Ma1, Eric Mangin1, Lynn R Webster2, Joan R Butterton1
1Merck Sharp & Dohme, Whitehouse Station, NJ, USA; 2Lifetree Clinical Research, Salt Lake City, UT, USA
![AASLD1.gif](../images/121613/121613-2/AASLD1.gif)
![AASLD2.gif](../images/121613/121613-2/AASLD2.gif)
![AASLD3.gif](../images/121613/121613-2/AASLD3.gif)
![AASLD4.gif](../images/121613/121613-2/AASLD4.gif)
![AASLD5.gif](../images/121613/121613-2/AASLD5.gif)
![AASLD6.gif](../images/121613/121613-2/AASLD6.gif)
![AASLD7.gif](../images/121613/121613-2/AASLD7.gif)
![AASLD8.gif](../images/121613/121613-2/AASLD8.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|